In this episode, Patrick Leung, CTO of Faro Health, explains how the company is using artificial intelligence to transform clinical trial design—a process that has long been slow, expensive, and inefficient. Drawing on his experience at Google and Two Sigma, he shares why he joined Faro and how the company’s mission is to accelerate the development of new therapies and bring them to patients faster.

Patrick describes how Faro’s AI-driven platform drastically reduces trial planning timelines, cutting what once took months down to just hours. He illustrates this impact through real-world examples with major pharmaceutical innovators like Merck and Recursion. Throughout the conversation, he emphasizes that while technology is a powerful enabler, true progress comes from blending AI innovation with clinical expertise and human insight.